Mark Mercola
14Patents
1h-index
23Co-inventors
54Inventor score
Filing activity: Dec 21, 1993 → Aug 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6475781B1 | Trans-dominant suppressor genes for oligomeric proteins | Human Necessities | 15 | Expired |
| US7910305B2 | Methods for screening for compounds that modulate insulin promoter activity | Chemistry; Metallurgy | 1 | Active |
| US7465585B1 | Compositions and methods for inhibiting cell migration | Human Necessities | 1 | Active |
| US11821003B2 | Cardiogenic mesoderm formation regulators | Chemistry; Metallurgy | 0 | Active |
| US8168391B2 | Method for modulating insulin production | Physics | 0 | Active |
| US7833980B2 | Compositions and methods for inhibiting cell migration | Human Necessities | 0 | Active |
| US9233926B2 | Compounds for stem cell differentiation | Chemistry; Metallurgy | 0 | Active |
| US9403800B2 | Compounds for inhibition of cancer cell proliferation | Chemistry; Metallurgy | 0 | Active |
| US10001470B2 | Method, system and composition for optically inducing cardiomyocyte contraction | Physics | 0 | Active |
| US10149922B1 | Engineered collagen matrices for myocardial therapy | Human Necessities | 0 | Active |
| US10682416B2 | Epicardial-derived paracrine factors for repairing cardiac tissue | Chemistry; Metallurgy | 0 | Active |
| US8039255B2 | Compositions and methods for inhibiting cell migration | Human Necessities | 0 | Active |
| US9023340B2 | Wnt inhibitors for human stem cell differentiation | Chemistry; Metallurgy | 0 | Active |
| US9012217B2 | Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.